Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03286543 · ClinicalTrials.gov registry record · NA
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
A NA study, sponsored by SPR Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03286543 is a NA study that has completed, run by SPR Therapeutics. The registered enrollment target is 47 participants.
The verdict
NCT03286543, a NA study, has completed, sponsored by SPR Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if electrical stimulation (small levels of electricity) in addition to the standard of care can safely and effectively reduce pain following total knee replacement more than the standard of care, alone. This study involves a device called the SPRINT Beta System. The SPRINT Beta System delivers mild electrical stimulation to nerves in the leg that received the knee replacement. The SPRINT Beta System includes a small wire (called a "lead") that is placed through the skin in the upper leg. It also includes a device worn on the body that delivers stimulation (called the SPRINT Beta Stimulator). About half the subjects in this study will receive the SPRINT Beta system (treatment group) and half will not (control group). Both groups will receive the standard of care.
Interventions
- DEVICE SPRINT Beta System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2020-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03286543
The ClinicalTrials.gov registry entry for NCT03286543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SPR Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SPRINT Beta System is the first listed.
NCT03286543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03286543 about?
NCT03286543 is a clinical study titled "Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System". The purpose of this study is to determine if electrical stimulation (small levels of electricity) in addition to the standard of care can safely and effectively reduce pain following total knee replacement more than the standard of care, alone. This study involves a device called the SPRINT Beta Sys...
What is the current status of trial NCT03286543?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-09-05. Estimated completion is 2020-04-15.
What interventions are being tested in trial NCT03286543?
The interventions under investigation include: SPRINT Beta System (DEVICE).
Who is sponsoring clinical trial NCT03286543?
This trial is sponsored by SPR Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.